1.81k likes | 14.01k Views
PREGNANCY INDUCED HYPERTENSION. Index. Diagnosis Etiology Pathogenesis Pathophysiology Prediction and Prevention Management Long-term consequences. Gestational Hypertension – 3.7% in 150,000 (National Center for Health Statics, 2001) Pregnancy-related hypertension :
E N D
Index • Diagnosis • Etiology • Pathogenesis • Pathophysiology • Prediction and Prevention • Management • Long-term consequences
Gestational Hypertension – 3.7% in 150,000 (National Center for Health Statics, 2001) • Pregnancy-related hypertension : • Pregnancy-related deaths (3201 in US, 1991-1997) • Black women are 3.1x to die as white women • Hypertensive disorders remain among the most significant and intriguing unsolved problems in obstetrics
Diagnosis • Gestational hypertension • Preeclampsia • Eclampsia • Superimposed preeclampsia (on chronic hypertension) • Chronic hypertension
Gestational hypertension • BP≥ 140/90mmHg for first time during pregnancy • No proteinuria • BP returns to normal < 12 weeks’ postpartum • Final diagnosis made only postpartum • May have other signs or symptoms of preeclampsia, for example, epigastric discomfort or thrombocytopenia
Preeclampsia ■ Minimum Criteria - BP ≥ 140/90 mmHg after 20 wks gestation - Proteinuria ≥ 300mg/24hrs or ≥1+ dipstick ■ Increased certainty of preeclampsia - BP ≥ 160/110 mmHg - Proteinuria 2.0g/24hrs or ≥2+dipstick - Serum creatinine >1.2mg/dl unless known to be previously elevated - Platelets < 100.000/mm3 - Microangiopathic hemolysis (Increased LDH) - Elevated ALT or AST - Persistent headache or other cerebral or visual disturbance - Persistent epigastric pain
Preeclampsia • Diastolic hypertension ≥ 95mmHg • Worsening proteinuria • Epigastric or RUQ pain • Thrombocytopenia • severe vasospasm → microangiopathic hemolysis → Platelet activation, aggregation
Severity of Preeclampsia • Differentiation between mild & severe preeclampsia can be misleading • because apparently mild disease may progress rapidly to severe disease • Rapid increase in BP followed by convulsions is usually preceded by unrelenting severe headache or visual disturbances.
Eclampsia • Preeclampsia + convulsion • Seizures that cannot be attributed to other causes in woman with preeclampsia • Seizures are generalizedand may appear before, during, of after labor
Chronic hypertension • BP ≥ 140/90 mmHg before pregnancy or diagnosed before 20 wks gestation (not attributable to gestational trophoblastic disease) or • Hypertension first diagnosed after 20 wks gestation and persistent after 12 wks postpartum
Chronic Hypertension • Chronic hypertension • BP decreases during the second and early third trimesters in both normotensive and chronically hypertensive women • Underlying hypertension • Essential familial hypertension (90%)
Underlying Causes of Chronic Hypertensive Disorder Essential familial hypertension (hypertensive vascular disease) Obesity Atrterial abnormalities Renovascular hypertension Coarctation of the aorta Endocrine diorders Diabetes mellitus Cushing syndrome Primary aldosteronism Pheochromocytoma Thyrotoxicosis Glomerulonephritis (acute and chronic) Renoprival hypertension Chronic glomerulonephritis Chronic renal insufficiency Diabetic nephropathy Connetive tissue disease Lupus erythematosus Systemic sclorosis Periarteritis nodosa Polycystic kidney disease Acute renal failure
Chronic Hypertension • Chronic HT • → ventricular hypertrophy, cardiac decompensation, cerebrovascular accidents, renal damage
Preeclampsia superimposed on Chronic Hypertension • New-onset proteinuria ≥ 300mg/24hours in hypertensive women but no proteinuria before 20 weeks’ gestation • A sudden increase in proteinuria or blood pressure or platelet count < 100,000/mm3 in women with hypertension and proteinuria before 20weeks’ gestation
Incidence and Risk Factor • Nulliparous women • Incidence : 5% (wide variation) • Influence by • Parity, race, ethnicity, genetic predisposition • Nulliparous • Total :7.6% / severe : 3.3% (Hauth, 2000) • Risk factor • Chronic hypertension, multifetal gestation, maternal old age(>35 yrs), obesity, African-American ethnicity
Incidence and Risk Factor • Maternal weight and the risk of preeclampsia is progressive. • Smoking during pregnancy reduced risk of hypertension during pregnancy (Bainbridge,2005 ; Zhang, 1999) • Placenta previa also reduced the risk of hypertension (Sibai, 2000)
Incidence and Risk Factor(Eclampsia) • Eclampsia • Somewhat preventable • Receive adquate prenatal care • 1976 (williams Obstetrics 15th edition) • 1/700 deliveries (Parkland Hospitial) • 1983-1986 • 1/1150 deliveries • 1999 • 1/1750 deliveries • 2000, National Vital Statistics Report, in US • 1/3250 • 1994, Douglas and Redman in UK • 1/2000
Etiology • Basic concepts • Exposed to chorionic villi for the first time • Exposed to a superabundance of chorionic villi, as with twins or hydatidiform mole • Have preexisting vascular disease • Genetically predisposed to hypertension developing during pregnancy
Etiology • Vascular endothelial damage with vasospasm, transudation of plasma, and ischemic and thrombotic sequelae. • Currently plausible potential cause (2003, Sibai) • Abnormal trophoblastic invasion of Uterine vessels • Immunological intolerance between maternal and fetoplacental tissues • Maternal maladaptation to cardiovascular or inflammatory changes of normal pregnancy • Diatary deficiencies • Genetic influences
Abnormal Trophoblastic Invasion • In normal implantation, endovascular trophoblasts invade the uterine spiral arteries
Abnormal Trophoblastic Invasion • In preeclampsia • Incomplete trophoblastic invasion • The magnitude of defective trophoblastic invasion of the spiral arteries correlated with the severity of the hypertensive disorder (2000, Madazli) • Using electron micorscopy • Endothelial damage • Insudation of plasma constituents into vessel walls • Proliferation of myointimal cells • Medial necrosis • Lipid and macrophage accumulates in myointimal cells
Lipid-laden cells → atherosis (Hertig, 1945) • Obstruction of the spiral arteriolar lumen by atherosis may impair placental blood flow • Placental perfusion → diminished
Immunological Factors • Theory • Formation of blocking antibodies of placental antigenic sites might be impaired. • Number of antigenic sites provided by the placenta is unusually great compared with the amount of antibody, as with multiple fetuses. (Beer, 1978) • Effective immunization by a previous pregnancy is lacking, as in first pregnancies. • The immunization concept was supported by their observations that preeclampsia developed less often in multiparas who had a prior term pregnancy (Mostello, 2002; Trupin, 1996)
Immunological Factors • Early second timester - Develop preeclampsia women • Lower proportion of helper T cells (Th1) • Th2 dominance, mediated by adenosine, which is found in higher serum level in preeclamptic compared with normotensive women (Yoneyama, 2002) • These helper T lymphocytes secrete specific cytokines that promote implantation, and their dysfunction may favor preeclampsia (Hayashi, 2004; Whitecar, 2001)
The Vasculopathy and the Inflammatory Changes • The decidua contains an abundance of cells that, when activated, can release noxious agents. (Staff, 1999) -> mediators to provoke endothelial cell injury • Preeclamsia due to an extreme state of activated leukocytes in the maternal circulation (Faas, 2000) • Cytokines : TNF-a, interleukin → oxidative stress (highly toxic radicals) • Potential benefit of antioxidants to prevent preeclampsia(Chappell, 1999; Zhang, 2002)
Nutritional Factors • Dietary deficiencies and Excesses over the centuries have been blamed as the cause of eclampsia. • Supplementation with various elements such as zinc, calcium, and magnesium to prevent preeclampsia(John, 2002) • Obesity, is a potent risk factor for preeclampsia • C-reactive protein, an inflammatory marker, was shown to be increase in obesity, which in turn was associated with preeclampsia (Wolf, 2001)
Genetic Factors • Hereditary hypertension is linked to preeclampsia (Ness, 2003) • Preeclampsia - eclampsia is highly heritable in sisters, daughters, granddaughter and daughters-in-law. (Chesley and Cooper, 1986) • 60% concordance in monozygotic female twin pairs(Nilsson, 2004) • HLA-DR4preeclampsia (Kilpatrick,1989)
PathogenesisVasospasm • Vascular constriction→resistance and subsequent hypertension • Maldistribution, ischemia of the surrounding tissues → blood flow→ necrosis, hemorrhage, and other end-organ disturbances
PathogenesisEndothelial cell activation • Unknown factors (from placenta) are secreted into the maternal circulation → activation and dysfunction of the vascular endothelium. • Damaged or activated endothelial cells secrete substances → promote coagulation and increase the sensitivity to vasopressors → changes in glomerular capillary endothelial morphology → increasd capillary permeability → elevated blood concentrations
Increased Pressor Responses • Normally, pregnant women develop refractoriness to infused vasopressors(Abdul-Karim an Assali, 1961) • But, early preeclampsia women have increased vascular reactivity to infused norepinephrine and angiotensin II(Raab, 1956)
Increased Pressor Responses Prostaglandins • In preeclampsia • Endothelial prostacyclin (PGI2) production is decreased • Thromboxane A2(TXA2) secretion by platelets is increased → Increased sensitivity to infused angiotensin II → vasoconstriction Membrane phospholipid Phospholipase A2 Arachidonic acid COX1,2 PGI2, PGE2 TXA2 Platelet
Increased Pressor ResponsesNitric oxide • Synthesized from L-arginine by endothelial cells. (potent vasodilator) • Nitric oxide maintains the normal low-pressure vasodilated state characteristic of fetoplacental perfusion(Myatt, 1992) • Preeclampsia is associated with decreased endothelial nitric oxide synthase expression, which increases cell permeability(Wang, 2004)
Increased Pressor Responses Endothelins • Endothelin-1 (ET-1) : • potent vasoconstrictors • produced by human endothelium • Plasma ET-1 is increased in normotensive pregnant women, but women with preeclampsia have even higher levels(Ajne, 2003 ; Clark, 1992)
Increased Pressor ResponsesAngiogenic factors • Vascular endothelial growth factor (VEGF), Placental growth factor (PIGF), • which secretion increases in normal pregnancy • Promote angiogenesis • Induce nitric oxide • Vasodilatory prostaglandins • Paradoxically, VEGF is increased in serum from women with preeclampsia, but its bioavailability is decreased (Baker, 1995 ; Simmons, 2000)
PathophysiologyCardiovascular System • Increased cardiac afterload caused by hypertension • Cardiac preload in preeclampsia • Pathologically diminished hypervolemia of pregnancy • Iatrogenically increased by iv crystalloid or oncotic solution • Extravasion into the extracellular space, especially the lung
Cardiovascular SystemHemodynamic Changes • Preeclampsia • Cardiac output elevated before hypertension developed than normal pregnancy. • With clinical onset of preeclampsia • Marked reduction in cardiac output. • Increased peripheral resistance. • By contrast, Gestational hypertension • Elevated cardiac outputs with development of hypertension.
Cardiovascular SystemBlood volume • Blood volume in term • Normal pregnancy : 5000ml • Not pregnancy : 3500ml • Eclampsia : 3500ml • Hemoconcentration in preeclampsia • Vasoconstriction and Endothelial dysfunction with vascular permeability. • Sevirity. • Whereas, gestational hypertension have a normal blood volume (Silver, 1998)
Cardiovascular SystemBlood volume • With severe hemoconcentration, an acute fall in hematocrit suggested resolution of preeclampsia • Intravascular compartment in eclamptic women is usually not underfilled. → vasospasm and endothelial leakage of plasma has contracted the space to be filled. → It persist some timeafter delivery when the vascular endothelium repairs. • Sensitive to vigorous fluid therapy to expand the contracted blood volume to normal pregnancy levels. • Sensitive to even normal blood loss at delivery.
Blood and CoagulationPlatelet • Thrombocytopenia → life threatening • Severe disease: < 100.000/uL • Platelet count → indication of delivery • Platelet activation, aggregation, consumption → “exhausion” → thrombocytopenia(Harlow, 2002) • HELLP syndrome : hemolysis (H) , elevated liver enzymes (EL), and low platelets (LP) (Weinstein, 982) • Neonatal thrombocytopenia • Maternal thrombocytopenia (Prichard, 1987)
Blood and CoagulationCoagulation • PT, aPTT, fibrinogen level (routine lab assessment of coagulation) → preeclampsiamanagement. • FDP: unknown (but, hepatic derangements (Leduc, 1992)) • Thrombophilias : • Clotting factor deficiencies → early onset preeclampsia • Antithrombin • Preeclampsia (Chang, 1992) • Fibronectin • Glycoprotein-vascular endothelial cell basement membrane • Preeclampsia
Blood and CoagulationFragmentation Hemolysis • Severe preeclampsia – hemolysis • Peripheral blood change : • Schizocytosis, spherocytosis, reticulocytosis
Volume HomeostasisFluid and Electrolyte Changes • Preclampsia • ECF • Pathologic retension : endothelial injury • Electrolyte concentration do not differ. • Electrolyte unbalance • Vigorous diuretic therapy • Sodium restriction • Administration of water with sufficient oxytocin to produce antidiuretisis. • Following eclamptic convertion -> lower HCO3
Kidney • Proteinuria • Preeclampsia-eclampsia • Late. • 24hr UA • Anatomical changes • Glomeruli : 20% • Glomerular capillary endotheliosis • Capillary endothelial swelling with subendothelial deposits of protein materials • Acute renal failure • Tubular necrosis, cortical necrosis -> oligouria, anuria, rapidly develped azotemia • HELLP synd. , placental abruption, postpartum hemorrhage
Liver • Periportal hemorrhagic necrosis in the periphery of the liver lobule • Serum liver enzyme • Nonfatal case • Hepatic rupture(more rare), subcapsular hematoma (more common). • Treatment • Surgical intervention, life saving가능 • Blood T/F. • Liver transplantation • Spontaneous hepatic rupture 의 mortality :30%